You just read:

Helsinn Grants Stendhal Rights to Anamorelin, a First-In-Class Compound to Treat Cachexia-Anorexia Related to Non-Small Cell Lung Cancer (NSCLC)

News provided by

Helsinn Healthcare SA

Jan 29, 2013, 08:00 EST